The value of disease-free survival (DFS) and osimertinib in adjuvant non-small-cell lung cancer (NSCLC): an international Delphi consensus report

  1. Hardenberg, M.C.
  2. Patel, B.
  3. Matthews, C.
  4. Califano, R.
  5. Garcia Campelo, R.
  6. Grohe, C.
  7. Hong, M.H.
  8. Liu, G.
  9. Lu, S.
  10. de Marinis, F.
  11. Pérol, M.
  12. Soo, R.A.
  13. Stiles, B.M.
  14. Tiseo, M.
  15. Tsuboi, M.
Journal:
ESMO Open

ISSN: 2059-7029

Year of publication: 2022

Volume: 7

Issue: 5

Type: Article

DOI: 10.1016/J.ESMOOP.2022.100572 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus